Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
04/23/1996 | US5510460 Peptide process |
04/23/1996 | US5510421 Crosslinking |
04/23/1996 | US5510331 Antihypertensive peptides |
04/23/1996 | US5510270 Generating pattern of light and dark areas by selectively irradiating surface areas; deprotecting; contacting with receptor to identify oligonucleotide showing complementarity to receptor |
04/23/1996 | US5510259 Isolated, purified dna having nucleotide sequence coding for said molecule |
04/23/1996 | US5510255 Plant fatty acid synthases |
04/23/1996 | US5510249 Fusion of signal peptide, a leader peptide, a heterogenous protein or polypeptide; genetic engineering |
04/23/1996 | US5510240 Method of screening a peptide library |
04/18/1996 | WO1996011210A1 Cyclic hexapeptides having antibiotic activity |
04/18/1996 | WO1996011208A1 Radioactive phosphorous labeling of proteins for targeted radiotherapy |
04/18/1996 | WO1996011205A1 Peptide nucleic acid conjugates |
04/18/1996 | DE19507166C1 Antibodies specific for fusion polypeptide(s) contg. a histidine component |
04/17/1996 | EP0706574A1 Methods for peptide synthesis and purification |
04/17/1996 | EP0706520A1 Novel cross-linking agents and use thereof |
04/17/1996 | EP0424519B1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship |
04/17/1996 | EP0290565B1 Vaccine containing tick antigens |
04/17/1996 | CN1120548A New pseudopeptide compounds of neurokinins, process for preparing them and pharmaceutical compositions containing them |
04/17/1996 | CN1120547A Method for prepn. of NTPS |
04/17/1996 | CN1120466A Reactor |
04/16/1996 | US5508382 Synthetic calcitonin |
04/16/1996 | US5508291 Treatment of feline vital disease; antitumor agents |
04/16/1996 | US5508263 A solid matrix having a protein coatings prepared from culturing two different nucleotide sequences; repairing bone defects |
04/16/1996 | US5508177 Lysing, fractionating, contacting with ion exchange resins, eluting, diluting, contacting with dye-ligand resin, eluting from dye-ligand resin |
04/16/1996 | US5508167 Detecting presence or absence of an apolipoprotein e type 4 isoform(apoe4) in subject by immunoassay |
04/11/1996 | WO1996010584A1 Process for extracting high-purity von willebrand factor |
04/11/1996 | WO1996010451A1 Access valve devices, their use in separation apparatus, and corresponding methods |
04/11/1996 | WO1996010415A1 Preparation of mhc-peptide complexes |
04/11/1996 | CA2201519A1 Preparation of mhc-peptide complexes |
04/10/1996 | EP0705846A1 High molecular weight and low molecular weight fractions of von Willebrand factor |
04/10/1996 | EP0705279A1 Topologically segregated, encoded solid phase libraries |
04/10/1996 | EP0705105A1 Metal chelates as spacer compounds in biologically active peptides |
04/10/1996 | EP0688316A4 Coupling method using selective amination of maleimide |
04/10/1996 | EP0559676B1 Precipitation process for exocellular proteins |
04/10/1996 | EP0537148B1 Purification of human interleukin-4 secreted from an escherichia coli mutant |
04/10/1996 | EP0507870B1 Polyhemoglobin stabilized by purine derivatives and glutathione |
04/10/1996 | CN1120340A Separation of proteins |
04/10/1996 | CN1120070A Point pallas pit viper poisonous fibre-dissolving enzyme and its purifying method |
04/10/1996 | CN1120047A New peptide compound and a process for the preparation thereof |
04/09/1996 | US5506362 Process for the preparation of an α-amino acid amide |
04/09/1996 | US5506258 Exhibit affinity for the biological receptors of neuropeptides y, which are present in the central and peripheral nervous systems |
04/09/1996 | US5506202 Insulin derivatives, a process for the preparation thereof, the use thereof, and a pharmaceutical formulation containing them |
04/09/1996 | US5506121 Fusion peptides with binding activity for streptavidin |
04/04/1996 | WO1996010176A1 Means for reversibly inactivating biological molecules |
04/03/1996 | EP0704457A1 Allergenic proteins of natural rubber latex, their production and use in assays |
04/03/1996 | EP0704440A1 A method of preparing N-formyl-L-aspartic anhydride |
04/03/1996 | EP0704221A2 A conjugate useful in gene transfer and a method of producing the same |
04/03/1996 | EP0703922A1 Immunoglobulin g concentrate for therapeutical use and method for producing same |
04/03/1996 | EP0703921A1 Grafted cross-linked polyolefin substrates for peptide synthesis and assays |
04/03/1996 | EP0703900A1 PROCESS FOR THE PREPARATION OF PHENYLALANINE DERIVATIVES OR HOMOLOGUES CONTAINING A GUANIDINO OR MODIFIED GUANIDINO GROUP USEFUL FOR THE PREPARATION GnRH OF ANTAGONISTIC PEPTIDES |
04/03/1996 | EP0703825A1 Method and apparatus for conducting an array of chemical reactions on a support surface |
04/03/1996 | EP0478715B1 Targeted liposomes and methods for liposome-protein coupling |
04/02/1996 | US5504190 Equimolar multiple oligomer mixtures, especially oligopeptide mixtures |
04/02/1996 | US5504188 Crystallization of lys(b28)pro(b29)-human insulin zinc salt at a ph of about 5.5 to 6.5 from a solution also containing acetic acid, citric acid, glycine or phenolic compound |
04/02/1996 | US5503989 Production of peptide amides |
04/02/1996 | US5503983 Incubating eluate with solid support precoated with antibodies washing, incubating second composition of antibodies with said solid support, washing, detecting antibodies bound to solid support |
04/02/1996 | US5503975 Mechanism based inhibitors of DNA methyltransferase |
04/02/1996 | US5503828 Alpha interferon composition and method for its production from human peripheral blood leukocytes |
04/02/1996 | US5503805 Apparatus and method for parallel coupling reactions |
04/02/1996 | CA2066370C Yield when disulfide-bonded proteins are secreted |
03/29/1996 | CA2159261A1 Method of preparing n-formyl-l-aspartic anhydride |
03/28/1996 | WO1996009411A1 Antigen binding peptides (abtides) from peptide libraries |
03/28/1996 | WO1996009116A1 Chromatographic resins and methods for using same |
03/28/1996 | CA2200684A1 Antigen binding peptides (abtides) from peptide libraries |
03/27/1996 | EP0702692A1 Regulation of antigen presentation |
03/27/1996 | EP0702674A1 Compound for protective and anchor groups and its use |
03/27/1996 | EP0607392A4 Plasma fraction purification. |
03/27/1996 | CN1119457A Bone stimulating factor |
03/27/1996 | CN1119121A Crystalline interleukin-4 |
03/26/1996 | US5502165 Process for peptide segment condensation |
03/26/1996 | US5502033 Antimicrobial polypeptide compound a pharmaceutical composition comprising the same, and a method for treating infectious diseases |
03/26/1996 | US5502032 Peptides, the preparation and use thereof |
03/26/1996 | US5502022 Chromatography adsorbents utilizing mercapto heterocyclic ligands |
03/26/1996 | US5501975 Transformed host cell, dibasic processing endoprotease, improved yield of correctly folded proteins |
03/26/1996 | US5501712 Method for crystallization of α-L-aspartyl-L-phenylalanine methyl ester |
03/26/1996 | CA1338183C Cyclic peptolides |
03/21/1996 | WO1996008781A1 System and method of automatically generating chemical compounds with desired properties |
03/21/1996 | WO1996008506A1 Phosphorus-32 labeling of antibodies for cancer therapy |
03/21/1996 | WO1996008264A1 Synthetic antibiotics |
03/21/1996 | DE4435485C1 Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor Process for the recovery of high purity von Willebrand factor |
03/21/1996 | DE4432943A1 Selection of peptide(s) with high binding affinity for target protein |
03/21/1996 | CA2200088A1 Phosphorus-32 labeling of antibodies for cancer therapy |
03/21/1996 | CA2199264A1 System and method of automatically generating chemical compounds with desired properties |
03/20/1996 | EP0701568A1 New peptide derivatives |
03/20/1996 | EP0701567A1 New peptides derivatives |
03/20/1996 | EP0701566A1 High salt binding buffer for immunoglobulin purification with a synthetic affinity ligand |
03/20/1996 | EP0701448A1 Amplification of the vitamin b 12? uptake system using polymers |
03/20/1996 | EP0449973B1 Polypeptide-polymer conjugates active in wound healing |
03/20/1996 | CN1119018A Purification of human interleukin-10 |
03/20/1996 | CN1031344C Process for preparing peptides inhibiting maturation of T-lymphocytes and activity of macrophages |
03/19/1996 | US5500414 Derivatives of peptides usable as inhibitors of bacterial collagenases |
03/19/1996 | US5500413 Process for manufacture of 1-deamino-8-D-arginine vasopressin |
03/19/1996 | US5500364 Pure mutants |
03/19/1996 | US5500362 Chimeric antibody with specificity to human B cell surface antigen |
03/19/1996 | US5500348 Basophil-binding monoclonal antibody, method for separation of basophils, method for chemical mediator release from basophils, and method for testing release of basophil-derived chemical mediators |
03/19/1996 | US5500347 Diagnosis of cancerous tumors and determination of their origin |
03/19/1996 | US5500229 Colostrum fraction, a process of preparing it and its use as a supplement in cell culture media |
03/19/1996 | CA2073012C Method for isolating factor viii |
03/14/1996 | WO1996007917A1 Automated molecular biological diagnostic system |
03/14/1996 | WO1996007916A1 Acetic anhydride activation for c-terminal protein sequencing |
03/14/1996 | WO1996007672A2 Protective and linking groups and their use (carbamides) |